Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00616707 · ClinicalTrials.gov registry record

Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds

A clinical trial of Inflammation, sponsored by University of California, Davis.

Completed
Registry status
68
Enrollment target
1
Study location

NCT00616707: Completed study of Inflammation, sponsored by University of California, Davis.

NCT00616707 is a study of Inflammation that has completed, run by University of California, Davis. The registered enrollment target is 68 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00616707, a study of Inflammation, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
68 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if there are signs of inflammation in one's blood and urine and to find out if one's body size or ethnicity has an effect on these substances.

Conditions Studied

Study Locations (1)

California

  • UC Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2006-08
Est. Completion 2009-10
University of California, Davis

657 total trials

What the finished NCT00616707 record still lists

NCT00616707 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 0 interventions.

NCT00616707 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00616707 about?

NCT00616707 is a clinical study titled "Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds". The purpose of this study is to determine if there are signs of inflammation in one's blood and urine and to find out if one's body size or ethnicity has an effect on these substances.

What is the current status of trial NCT00616707?

This trial is currently completed. The enrollment target is 68 participants. The study started on 2006-08. Estimated completion is 2009-10.

What conditions does trial NCT00616707 study?

This clinical trial studies the following conditions: Inflammation.

Who is sponsoring clinical trial NCT00616707?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00616707 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00616707's enrollment target sits among peer trials

68 61st of 132 higher than 72 of 132 other Inflammation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00616707, the US trial registry maintained by the National Library of Medicine. NCT00616707 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.